EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis

Jun Li iD, Yifan Zhou, Xuetong Wu iD, Guo Cheng, Qun Ma, Yixue Zhou, Nannan Zhang iD

Journal of Diabetes Research · 2026

DOI: 10.1155/jdr/9073132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Jun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Chinese Medicines, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Stilbenes, Apoptosis, Tumor Necrosis Factor-alpha. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Education Innovation Projects of Guizhou University of Traditional Chinese Medicine, Guizhou Provincial Department of Education Youth Science and Technology Talents Growth Project, Guizhou Provincial Basic Research Program (General Program).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic β ‐apoptosis is a critical pathological event in diabetes mellitus (DM), yet effective therapeutic agents that directly protect β ‐cells are lacking. Polydatin (PD), a natural stilbenoid, has shown potential in regulating glucolipid metabolism; however, its role and mechanism in protecting pancreatic β ‐cells from apoptosis remain largely unexplored.

Objective

The present work focused on investigating whether PD prevents pancreatic β ‐cells against diabetes‐related apoptosis and exploring the associated molecular mechanisms, with a particular focus on the TNF/TNF‐R1/caspase‐3 signaling axis.

Methods

Network pharmacology and bioinformatics were applied in combination with experimental validation. Potential targets of PD and DM were retrieved from public databases. Key candidate targets were screened via protein–protein interaction (PPI) analysis, least absolute shrinkage and selection operator (LASSO) regression, functional enrichment (GO/KEGG), differential expression, receiver operating characteristic (ROC), and clinical correlation analyses. Binding interactions were assessed by molecular docking alongside dynamic simulations. In vitro and in vivo DM models were established with high glucose (HG)–stimulated MIN6 β ‐cells and high‐fat/HG diet‐fed mice with low‐dose streptozotocin (STZ) administration, respectively.

Results

TNF was identified as a central target of PD against DM, with elevated expression under diabetic conditions and a significant correlation with fasting blood glucose levels. PD exhibited strong binding affinity to both TNF (Vina score: –8.9 kcal·mol −1 ) and TNF‐R1 (Vina score: –8.8 kcal·mol −1 ). Cellular experiments demonstrated that PD enhanced β ‐cell cycle progression (upregulated Ki67 expression), downregulated TNF‐R1 expression, and facilitated insulin secretion under HG stimulation. In diabetic mice, PD significantly increased the islet β ‐cell mass and area; downregulated the expression of TNF, TNF‐R1, and cleaved‐caspase‐3; and restored PARP1 expression.

Conclusion

This study revealed that PD attenuated diabetic β ‐apoptosis, likely through inhibition of the TNF/TNF‐R1/caspase‐3 pathway, suggesting that PD may be a novel anti‐DM therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsStilbenesApoptosisTumor Necrosis Factor-alphaSignal TransductionCaspase 3GlucosidesReceptors, Tumor Necrosis Factor, Type IDiabetes Mellitus, ExperimentalAnimalsMiceMolecular Docking SimulationMaleMice, Inbred C57BL

Substanzen

StilbenesTumor Necrosis Factor-alphapolydatinCaspase 3GlucosidesReceptors, Tumor Necrosis Factor, Type I

Autor:innen und Institutionen

  • School of Basic Chinese Medicines, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
  • School of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
  • School of First Clinical Medical, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
  • School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.

ORCID-Profile: Jun Li, Xuetong Wu, Nannan Zhang

Förderung

  • Graduate Education Innovation Projects of Guizhou University of Traditional Chinese Medicine
  • Guizhou Provincial Department of Education Youth Science and Technology Talents Growth Project
  • Guizhou Provincial Basic Research Program (General Program)

Zitieren

APA

Li, J., Zhou, Y., Wu, X., Cheng, G., Ma, Q., Zhou, Y., & Zhang, N. (2026). Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis. Journal of Diabetes Research. https://doi.org/10.1155/jdr/9073132

Vancouver

Li J, Zhou Y, Wu X, Cheng G, Ma Q, Zhou Y, et al. Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis. Journal of Diabetes Research. 2026. doi:10.1155/jdr/9073132

BibTeX
@article{Li2026,
  author = {Li, Jun and Zhou, Yifan and Wu, Xuetong and Cheng, Guo and Ma, Qun and Zhou, Yixue and Zhang, Nannan},
  title = {Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis},
  journal = {Journal of Diabetes Research},
  year = {2026},
  doi = {10.1155/jdr/9073132}
}
Kostenlos starten →